11-2143569-G-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001007139.6(IGF2):​c.-7+3997C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.888 in 151,972 control chromosomes in the GnomAD database, including 60,364 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.89 ( 60364 hom., cov: 29)

Consequence

IGF2
NM_001007139.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.49

Publications

5 publications found
Variant links:
Genes affected
IGF2 (HGNC:5466): (insulin like growth factor 2) This gene encodes a member of the insulin family of polypeptide growth factors, which are involved in development and growth. It is an imprinted gene, expressed only from the paternal allele, and epigenetic changes at this locus are associated with Wilms tumour, Beckwith-Wiedemann syndrome, rhabdomyosarcoma, and Silver-Russell syndrome. A read-through INS-IGF2 gene exists, whose 5' region overlaps the INS gene and the 3' region overlaps this gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2010]
INS-IGF2 (HGNC:33527): (INS-IGF2 readthrough) This locus includes two alternatively spliced read-through transcript variants which align to the INS gene in the 5' region and to the IGF2 gene in the 3' region. One transcript is predicted to encode a protein which shares the N-terminus with the INS protein but has a distinct and longer C-terminus, whereas the other transcript is a candidate for nonsense-mediated decay (NMD). The transcripts are imprinted and are paternally expressed in the limb and eye. [provided by RefSeq, Jul 2008]
IGF2-AS (HGNC:14062): (IGF2 antisense RNA) This gene is expressed in antisense to the insulin-like growth factor 2 (IGF2) gene and is imprinted and paternally expressed. It is thought to be non-coding because the putative protein is not conserved and translation is predicted to trigger nonsense mediated decay (NMD). Transcripts from this gene are produced in tumors and may function to suppress cell growth. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2015]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.976 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001007139.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IGF2
NM_001007139.6
c.-7+3997C>G
intron
N/ANP_001007140.2P01344-1
INS-IGF2
NR_003512.4
n.708+3997C>G
intron
N/A
IGF2-AS
NR_028043.2
n.436+2622G>C
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ENSG00000284779
ENST00000643349.2
c.*46+3997C>G
intron
N/AENSP00000495715.1A0A2R8Y747
IGF2
ENST00000481781.3
TSL:5
c.-7+3997C>G
intron
N/AENSP00000511998.1P01344-1
IGF2
ENST00000695541.1
c.-7+3997C>G
intron
N/AENSP00000511997.1P01344-1

Frequencies

GnomAD3 genomes
AF:
0.888
AC:
134802
AN:
151860
Hom.:
60320
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.764
Gnomad AMI
AF:
0.993
Gnomad AMR
AF:
0.930
Gnomad ASJ
AF:
0.930
Gnomad EAS
AF:
0.999
Gnomad SAS
AF:
0.956
Gnomad FIN
AF:
0.940
Gnomad MID
AF:
0.914
Gnomad NFE
AF:
0.928
Gnomad OTH
AF:
0.879
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.888
AC:
134903
AN:
151972
Hom.:
60364
Cov.:
29
AF XY:
0.891
AC XY:
66179
AN XY:
74272
show subpopulations
African (AFR)
AF:
0.765
AC:
31647
AN:
41392
American (AMR)
AF:
0.930
AC:
14204
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.930
AC:
3229
AN:
3472
East Asian (EAS)
AF:
0.999
AC:
5143
AN:
5150
South Asian (SAS)
AF:
0.957
AC:
4577
AN:
4784
European-Finnish (FIN)
AF:
0.940
AC:
9957
AN:
10594
Middle Eastern (MID)
AF:
0.914
AC:
267
AN:
292
European-Non Finnish (NFE)
AF:
0.928
AC:
63119
AN:
67996
Other (OTH)
AF:
0.881
AC:
1854
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
704
1408
2111
2815
3519
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
898
1796
2694
3592
4490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.908
Hom.:
3090
Bravo
AF:
0.879
Asia WGS
AF:
0.973
AC:
3383
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.41
DANN
Benign
0.31
PhyloP100
-1.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4366464; hg19: chr11-2164799; API